GSK Plans To Set Up New Manufacturing Units In Nashik, Maharashtra

World’s second major drug maker, GlaxoSmithKline (GSK) has made GSK Plans To Set Up New Manufacturing Units In Nashik, Maharashtraannouncement that the company is proposing to build a new manufacturing production line in Nashik, Maharashtra with the aim to produce 300 million tablets of albendazole per year for curing Lymphatic Filariasis (LF).

Lymphatic Filariasis (Philariasis) is a parasitic and infectious tropical disease that is caused by thread-like parasitic worms, of the type filarial nematode.

According to the sources, production will commence in late 2008 and will double GSK`s present worldwide albendazole capacity. GSK will pump around Rs 1.7 million in the facility as well as converting existing equipment to generate the tablets for donation.

WHO`s Worldwide Programme to Eradicate Lymphatic Filariasis, uses once-yearly treatment for at-risk individuals using albendazole plus either Mectizan or diethylcarbamazine (DEC), supplied by GSK and Merck & co. 

Stock of GlaxoSmithKline Pharmaceuticals ended the day (8, Oct, Wednesday) at Rs 1,092 on National Stock Exchange (NSE).